Medical Science Laison sHTG

Medical Science Liaison sHTG

Statistics show that women and underrepresented groups tend to apply to jobs only if they meet 100% of the qualifications. Sobi encourages you to change that statistic and apply. Rarely do candidates meet 100% of the qualifications. We look forward to your application!

At Sobi, each person brings their unique talents to work as a team and make a difference. We are dedicated to developing and delivering innovative therapies to improve the lives of people who live with a rare disease. Our edge comes from our team of people and our commitment to patients.

Here at Sobi, our mission and culture get us excited to come to work every day, but here are a few more reasons to join our team:

• Competitive compensation for your work
• Emphasis on work/life balance
• Collaborative and team-oriented environment
• Opportunities for professional growth
• Diversity and Inclusion
• Making a positive impact to help ultra-rare disease patients who are in need of life saving treatments

The Medical Science Liaison (MSL) is a field‑based scientific expert responsible for engaging healthcare professionals, clinical experts, and key external stakeholders in support of the agreed medical strategy for Tryngolza, an innovative therapy for Familial Chylomicronemia Syndrome (FCS), with future potential in Severe Hypertriglyceridemia (sHTG).

This position can be based in Cologne, Düsseldorf, Dortmund, Münster, Trier, Koblenz, Bonn, and other cities in Germany.

In this role, you will drive scientific exchange, support clinical and evidence‑generation initiatives, gather actionable insights, and partner cross‑functionally to ensure consistent, high-quality scientific standards. The position plays a critical part in enhancing understanding of rare lipid disorders, supporting patient pathways, and enabling informed, ethical decision‑making.

Executes field medical activities in accordance with Medical Excellence standards, including qualitative insights capture, engagement planning discipline, and agreed performance measures.

Key Responsibilities/Scope of the Job

• External Scientific Engagement
  • Serve as the primary field‑based medical and scientific expert for Tryngolza within the sHTG community.
  • Build and maintain strong, trusted relationships with:
    • Key opinion leaders (KOLs)
    • Healthcare professionals
    • Academic researchers
  • Conduct non‑promotional scientific discussions on disease pathways, clinical evidence, patient management, and emerging data, in line with approved medical content.
  • Ensure high‑quality, balanced scientific exchange and clear communication of relevant information.
  • Develop and maintain stakeholder engagement plans aligned to Medical Excellence guidance (segmentation, objectives, scientific exchange plans, and documentation)
• Insight Generation & Strategic Contribution
  • Gather and communicate actionable insights from HCP interactions, scientific meetings, and stakeholder activities.
  • Share insights with Medical Affairs colleagues to shape:
    • Medical strategy
    • Evidence‑generation priorities
    • Stakeholder engagement plans
    • Educational programs
    • Key account plans in a cross-functional manner
  • Identify and communicate emerging gaps in diagnosis, treatment access, and unmet needs.
  • Contribute to periodic insight reviews (e.g., monthly/quarterly) to support cross-country visibility and strategic decision-making
• Medical Education & Scientific Support
  • Deliver scientific education to HCPs, centers, and relevant networks.
  • Support the Medical Advisor in developing educational content, disease‑awareness programs, and scientific resources.
  • Provide scientific training and support to internal teams (e.g., commercial, patient access, field teams) to ensure accuracy, consistency and compliance.
  • Support advisory boards, congress activities, and expert meetings.
  • Deliver and support education initiatives following Medical Excellence quality standards.
• Clinical Research & Evidence Generation
  • Contribute to evidence‑generation activities including:
    • Phase IIIb/IV studies
    • Investigator‑initiated research (ISS/ISR)
    • Non‑interventional studies, registries, RWE programs
    • Patient identification and site feasibility discussions
  • Engage with investigators and sites to…